Browse Title Index

Issue Title
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist Algorithm for the treatment of advanced or metastatic squamous non-small-cell lung cancer: an evidence-based overview Abstract   PDF   HTML
N. Daaboul, G. Nicholas, S. A. Laurie
Vol 20, No 1 (2013) Alignment of practice guidelines with targeted-therapy drug funding policies in Ontario Abstract   PDF   HTML
R. Ramjeesingh, R.M. Meyer, M. Brouwers, B.E. Chen, C.M. Booth
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist ALK inhibitors, resistance development, clinical trials Abstract   PDF   HTML
J.M. Rothenstein, N. Chooback
Vol 20, No 4 (2013) Aloe vera for prevention of radiation-induced dermatitis: a self-controlled clinical trial Abstract   PDF   HTML
P. Haddad, F. Amouzgar-Hashemi, S. Samsami, S. Chinichian, M.A. Oghabian
Vol 19, No 2 (2012) Alternative and orthodox medicine and the “odd” principle Abstract   PDF   HTML
L.Z.G. Touyz
Vol 18, No 2 (2011) An appraisal of life’s terminal phases and euthanasia and the right to die Details   PDF   HTML
L. Z.G. Touyz, S. J.J. Touyz
Vol 15, No 2 (2008) An Approach to the Management of Chronic Myeloid Leukemia in British Columbia Details   PDF
Donna Lynn Forrest, X Jiang, C Eaves, C Smith
Vol 24, No 6 (2017) An evaluation of the behaviour-change techniques used on Canadian cancer centre Web sites to support physical activity behaviour for breast cancer survivors Abstract   PDF   HTML
B.D. Sylvester, K. Zammit, A.J. Fong, C.M. Sabiston
Vol 22, No 3 (2015) An exploratory comparative analysis of tyrosine kinase inhibitors or docetaxel in second-line treatment of EGFR wild-type non-small-cell lung cancer: a retrospective real-world practice review at a single tertiary care centre Abstract   PDF   HTML
K. Ma, V. Cohen, G. Kasymjanova, D. Small, K. Novac, J. Peterson, A. Levitt, J. Agulnik
Jane Maher
Vol 22, No 3 (2015) An intermediate step for the management of hypersensitivity to platinum and taxane chemotherapy Abstract   PDF   HTML
M. Bahl, T. Dean
Vol 20, No 6 (2013) An interprofessional palliative care oncology rehabilitation program: effects on function and predictors of program completion Abstract   PDF   HTML
M.R. Chasen, A. Feldstain, D. Gravelle, N. MacDonald, J. Pereira
Vol 22, No 4 (2015) An open-label expanded-access trial of bendamustine in patients with rituximab-refractory indolent non-Hodgkin lymphoma or previously untreated chronic lymphocytic leukemia: BEND-ACT Abstract   PDF   HTML
C.T. Kouroukis, M. Crump, D. MacDonald, J.F. Larouche, D.A. Stewart, J. Johnston, S. Sauvageau, E. Beausoleil, P. Sage, S.G. Dubois, A. Christofides, S. Di Clemente, L. Sehn
Vol 16 (2009): Endocrine Therapy Update Supplement An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor–positive early breast cancer Abstract   PDF
S. Verma, S. Sehdev, A Joy, Y. Madarnas, J. Younus, J. A. Roy
Vol 15, No 5 (2008) Anal Cancer and Human Papillomaviruses in Heterosexual Men Abstract   PDF
Alan Nyitray
Vol 20, No 2 (2013) Analysis of intraprostatic therapeutic effects in prostate cancer patients using [11C]-choline PET/CT after external-beam radiation therapy Abstract   PDF   HTML
J. Amanie, H.S. Jans, M. Wuest, N. Pervez, A. Murtha, N. Usmani, D. Yee, R. Pearcey, B. Danielson, S. Patel, R. Macewan, C. Field, D. Robinson, J. Wilson, D. Lewis, M. Parliament, A.J.B. McEwan
Vol 22, No 6 (2015) Analysis of liver-directed therapies in U.S. cancer patients Abstract   PDF   HTML
O.B. Alese, S. Kim, Z. Chen, S.S. Ramalingam, T.K. Owonikoko, B.F. El-Rayes
Vol 22, No 2 (2015) Analysis of sebum lipid composition and the development of acneiform rash before and after administration of egfr inhibitor Abstract   PDF   HTML
T. Nakahara, Y. Moroi, K. Takayama, Y. Nakanishi, M. Furue
Vol 25, No 3 (2018) Anastomosing hemangioma of the kidney: radiologic and pathologic distinctions of a kidney cancer mimic Abstract   PDF   HTML
P.M. Cheon, R. Rebello, A. Naqvi, S. Popovic, M. Bonert, A. Kapoor
Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective Androgen deprivation therapy for prostate cancer—review of indications in 2010 Abstract   PDF
H. Quon, D.A. Loblaw
Vol 19 (2012): Improving Patient Outcomes in Advanced Prostate Cancer Androgen deprivation therapy in advanced prostate cancer: is intermittent therapy the new standard of care? Abstract   PDF   HTML
L. Klotz, P. Toren
Vol 14, No 6 (2007) Anemia is a common but neglected complication of adjuvant chemotherapy for early-stage breast cancer Details   PDF
Amanda Goldrick, Ivo A Olivotto, Cheryl Alexander, Caroline H Speers, Jeff Barnett, Sharon J Allan, Pauline T Truong
Vol 23, No 6 (2016) Annual surveillance mammography after early-stage breast cancer and breast cancer mortality Abstract   PDF   HTML
L.E. Paszat, R. Sutradhar, S. Gu, E. Rakovitch
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist Antiangiogenic therapies in non-small-cell lung cancer Abstract   PDF   HTML
A. Alshangiti, G. Chandhoke, P.M. Ellis
Vol 21, No 1 (2014) Anticancer activity of combination targeted therapy using cetuximab plus vemurafenib for refractory BRAFV600E-mutant metastatic colorectal carcinoma Abstract   PDF   HTML
K. Connolly, D. Brungs, E. Szeto, R.J. Epstein
Vol 23 (2016): Use of Cannabinoids in Cancer Care Anticancer mechanisms of cannabinoids Abstract   PDF   HTML
G. Velasco, C. Sánchez, M. Guzmán
Vol 17, No 4 (2010) Aplastic anemia with concurrent temozolomide treatment in a patient with glioblastoma multiforme Abstract   PDF
J. Oh, G.J. Kutas, P. Davey, M. Morrison, J.R. Perry
Vol 17, No 1 (2010) Application of machine learning methodology for PET-based definition of lung cancer Abstract   PDF
A. Kerhet, C. Small, H. Quon, T. Riauka, L. Schrader, R. Greiner, D. Yee, A. McEwan, W. Roa
Vol 23, No 3 (2016) Approach to biomarker testing: perspectives from various specialties Abstract   PDF   HTML
M.R. Sung, P.M. Ellis, S. Verma, E. Duncan, N.B. Leighl
Vol 23, No 4 (2016) Approach to fever assessment in ambulatory cancer patients receiving chemotherapy: a clinical practice guideline Abstract   PDF   HTML
M.K. Krzyzanowska, C. Walker-Dilks, C. Atzema, A. Morris, R. Gupta, R. Halligan, T. Kouroukis, K. McCann
Vol 21, No 6 (2014) Aprepitant and granisetron for the prophylaxis of radiotherapy-induced nausea and vomiting after moderately emetogenic radiotherapy for bone metastases: a prospective pilot study Abstract   PDF   HTML
K. Dennis, C. De Angelis, F. Jon, N. Lauzon, M. Pasetka, L. Holden, E. Barnes, C. Danjoux, A. Sahgal, M. Tsao, E. Chow
Vol 19, No 5 (2012) Are bilateral cancers hereditary? Part II Details   PDF   HTML
S. Narod
Vol 15, No 4 (2008) Are Matrix Metalloproteinases Relevant Therapeutic Targets for Prostate Cancer Bone Metastasis? Abstract   PDF
R. Daniel Bonfil, Rafael Fridman, Shahriar Mobashery, Michael L. Cher
Vol 22, No 5 (2015) Are patients receiving the right care in the right place at the right time? Abstract   PDF   HTML
M. Chasen, N. Dosani
Vol 20, No 4 (2013) Are two-centimeter breast cancers large or small? Abstract   PDF   HTML
S.A. Narod, J. Iqbal, A. Jakubowska, T. Huzarski, P. Sun, C. Cybulski, J. Gronwald, T. Byrski, J. Lubinski
Vol 25, No 2 (2018) Aromatase inhibitors in premenopausal women with breast cancer: the state of the art and future prospects Abstract   PDF   HTML
M. Pistelli, A. Della Mora, Z. Ballatore, R. Berardi
Vol 18, No 5 (2011) Array comparative genomic hybridization and cytogenetic analysis in pediatric acute leukemias Abstract   PDF   HTML
A. J. Dawson, R. Yanofsky, R. Vallente, S. Bal, I. Schroedter, L. Liang, S. Mai
Vol 17, No 6 (2010) Arterial embolization for ruptured adrenal pheochromocytoma Abstract   PDF
M. Habib, I. Tarazi, M. Batta
Vol 17, No 6 (2010) Arterial occlusion precipitated by cisplatin-based chemotherapy Abstract   PDF
D. Joseph, B. Dubashi, B. Karthikeyan, A. Jain
Vol 24, No 4 (2017) ASCO 2017 meeting summary: updates to practice-changing studies in untreated non-Hodgkin lymphoma Abstract   PDF   HTML
P. Laneuville, J.F. Larouche, A. Tosikyan, A. Christofides
Vol 20, No 2 (2013) Assessing fitness to drive in brain tumour patients: a grey matter of law, ethics, and medicine Abstract   PDF   HTML
A.V. Louie, E. Chan, M. Hanna, G.S. Bauman, B.J. Fisher, D.A. Palma, G.B. Rodrigues, A. Warner, D.P. D'Souza
Vol 25, No 1 (2018) Assessing post-radiotherapy handover notes from a family physician perspective Abstract   PDF   HTML   Supplemental Materials
A. Dang, S. Miller, D. Horvat, T. Klassen-Ross, M. Graveline, R. Collins, R. Olson
Vol 18, No 6 (2011) Assessment and management of febrile neutropenia in emergency departments within a regional health authority—a benchmark analysis Abstract   PDF   HTML
D. Szwajcer, P. Czaykowski, D. Turner
Vol 19, No 3 (2012) Assisted death and the slippery slope—finding clarity amid advocacy, convergence, and complexity Abstract   PDF   HTML
M.J. Shariff
Vol 23, No 5 (2016) Association between basal-like phenotype and BRCA1/2 germline mutations in Korean breast cancer patients Abstract   PDF   HTML
J. Jung, E. Kang, J.M. Gwak, A.N. Seo, S.Y. Park, A.S. Lee, H. Baek, S. Chae, E.K. Kim, S.W. Kim
Vol 17, No 5 (2010) Association of lipid metabolism with ovarian cancer Abstract   PDF
M. Tania, M.A. Khan, Y. Song
Vol 23, No 3 (2016) Astragalus-containing Traditional Chinese Medicine, with and without prescription based on syndrome differentiation, combined with chemotherapy for advanced non-small-cell lung cancer: a systemic review and meta-analysis Abstract   PDF   HTML
S.F. Wang, Q. Wang, L.J. Jiao, Y.L. Huang, D. Garfield, J. Zhang, L. Xu
Vol 25, No 2 (2018) Ataxia–telangiectasia gene (ATM) mutation heterozygosity in breast cancer: a narrative review Abstract   PDF   HTML
K.J. Jerzak, T. Mancuso, A. Eisen
Vol 18, No 6 (2011) Author Index Abstract   PDF   HTML
Current Oncology
Vol 19, No 6 (2012) Author Index Details   PDF   HTML
Current Oncology
Vol 20, No 6 (2013) Author Index Details   PDF   HTML
Various Authors
Vol 21, No 6 (2014) Author Index Abstract   PDF   HTML
Various Authors
Vol 13, No 1 (2006) Awareness and Use of the Rapid Palliative Radiotherapy Program by Family Physicians in Eastern Ontario: A Survey Details   PDF
E J Fitzgibbon
Vol 20, No 3 (2013) Axillary lymph node status, adjusted for pathologic complete response in breast and axilla after neoadjuvant chemotherapy, predicts differential disease-free survival in breast cancer Abstract   PDF   HTML
G.C. Zhang, Y.F. Zhang, F.P. Xu, X.K. Qian, Z.B. Guo, C.Y. Ren, M. Yao
Vol 25, No 1 (2018) Azacitidine-induced pyoderma gangrenosum at injection sites in a patient with myelodysplastic syndrome Abstract   PDF   HTML
C. Roy, J.P. Adam, F. Morin, É. Lemieux-Blanchard, S. Doucet, D. Friedmann, A. Belisle, D. Charpentier
Vol 17, No 3 (2010) Balancing potential quality-of-life benefits against the risk of lethal late recurrence with bladder-preserving surgery Abstract   PDF
L. Klotz
Vol 25, No 2 (2018) Barriers to participation in clinical trials: a physician survey Abstract   PDF   HTML
A. Mahmud, O. Zalay, A. Springer, K. Arts, E. Eisenhauer
Vol 20, No 5 (2013) Benefits, issues, and recommendations for personalized medicine in oncology in Canada Abstract   PDF   HTML
C. Butts, S. Kamel–Reid, G. Batist, S. Chia, C. Blanke, M. Moore, M.B. Sawyer, C.C. Desjardins, A. Dubois, J. Pun, K. Bonter, Fredrick D Ashbury
Vol 17, No 5 (2010) Bevacizumab in combination with FOLFIRI chemotherapy in patients with metastatic colorectal cancer: an assessment of safety and efficacy in the province of Newfoundland and Labrador Abstract   PDF
G. Dranitsaris, S. Edwards, J. Edwards, M. Leblanc, R. Abbott
Vol 20, No 5 (2013) Bevacizumab-based therapy for colorectal cancer: experience from a large Canadian cohort at the Jewish General Hospital between 2004 and 2009 Abstract   PDF   HTML
N. Bouganim, A. Mamo, D.W. Wasserman, G. Batist, P. Metrakos, P. Chaudhury, M. Hassanain, P. Kavan
Vol 22, No 3 (2015) Beyond the mammography debate: a moderate perspective Abstract   PDF   HTML
C. Kaniklidis
Vol 21, No 1 (2014) Bilineal T lymphoblastic and myeloid blast transformation in chronic myeloid leukemia with TP53 mutation—an uncommon presentation in adults Abstract   PDF   HTML
S. Krishnan, K. Sabai, C. Chuah, S.Y. Tan
Vol 15, No 2 (2008) Biochemotherapy for the Treatment of Metastatic Malignant Melanoma: A Clinical Practice Guideline Abstract   PDF
Denise Stys-Norman
Vol 23, No 5 (2016) Bioelectrical impedance phase angle as a prognostic indicator of survival in head-and-neck cancer Abstract   PDF   HTML
M.S. Wladysiuk, R. Mlak, K. Morshed, W. Surtel, A. Brzozowska, T. Małecka-Massalska
Vol 21, No 4 (2014) Biologic, psychological, and social health needs in cancer care: how far have we come? Abstract   PDF   HTML
F. Schulte
Vol 13, No 1 (2006) Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma Details   PDF
Lara J Williams, Duane L Guernsey, Alan G Casson
Vol 19 (2012): Personalized Medicine in Metastatic NSCLC: a Canadian Perspective Biomarkers that currently affect clinical practice: EGFR, ALK, MET, KRAS Abstract   PDF   HTML
M.D. Vincent, M.S. Kuruvilla, N.B. Leighl, S. Kamel-Reid
Vol 16, No 6 (2009) Bogarting that joint might decrease oral HPV among cannabis users Abstract   PDF
S. Zwenger
Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective Bone health in nonmetastatic prostate cancer: what’s the big deal? Abstract   PDF
J.B. Lattouf, F. Saad
Vol 19, No 5 (2012) Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art Abstract   PDF   HTML
M. Clemons, K.A. Gelmon, K.I. Pritchard, A.H.G. Paterson
Vol 17, No 4 (2010) BONUS 5: 5th Annual Bone and The Oncologist New Updates Abstract   PDF
N. Bouganim, E. Amir, M. Clemons
Vol 23, No 5 (2016) Book review: Balanced Ethics Review: A Guide for Institutional Review Board Members Abstract   PDF   HTML
T. Christie
Vol 23, No 1 (2016) Book review: Hypnotic Approaches in Cancer and Palliative Care Abstract   PDF   HTML
G. Giddings
Vol 22, No 3 (2015) Book review: Therapeutic Revolution: The History of Medical Oncology From Early Days to the Creation of the Subspecialty Abstract   PDF   HTML
C.I. Falkson
Vol 22, No 3 (2015) Book review: Therapeutic Revolution: The History of Medical Oncology From Early Days to the Creation of the Subspecialty Abstract   PDF   HTML
G. Giddings
Vol 22, No 3 (2015) Book review: Therapeutic Revolution: The History of Medical Oncology From Early Days to the Creation of the Subspecialty Abstract   PDF   HTML
J. Ragaz, S. Shakeraneh
Vol 13, No 5 (2006) Bortezomib in Multiple Myeloma and Lymphoma: A systematic review and clinical practice guideline Details   PDF
Christopher A Smith
Vol 21, No 4 (2014) Bortezomib in multiple myeloma: systematic review and clinical considerations Abstract   PDF   HTML
T.C. Kouroukis, F.G. Baldassarre, A.E. Haynes, K. Imrie, D.E. Reece, M.C. Cheung
Vol 21, No 6 (2014) BRAF mutation correlates with recurrent papillary thyroid carcinoma in Chinese patients Abstract   PDF   HTML
W.Y. Fang, L. Ye, X.F. Zhang, L.Y. Shen, R.L. Han, Q. Wei, X.C. Fei, X. Chen, W.Q. Wang, S. Wang, G. Ning
Vol 16, No 1 (2009) Brain Metastases from Unknown Primary or Primary Brain Tumor: A Diagnostic Dilemma Details   PDF
Sarah Campos, Philip Davey, Amanda Hird, Bryn Pressnail, Juan Bilbao, Richard Aviv, Sean Symons, Farhad Pirouzmand, Emily Sinclair, Shaelyn Culleton, Eric deSa, Philiz Goh, Edward Chow
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist Brain metastases in non-small-cell lung cancer: are tyrosine kinase inhibitors and checkpoint inhibitors now viable options? Abstract   PDF   HTML
S. Morin-Ben Abdallah, A. Wong
Vol 22, No 4 (2015) BRCA1/2 population screening: embracing the benefits Abstract   PDF   HTML
S.E. Plon
Vol 18, No 1 (2011) Breaking new ground in a new year Details   PDF   HTML
M. McLean
Vol 21, No 5 (2014) Breast and cervical cancer screening behaviours among colorectal cancer survivors in Nova Scotia Abstract   PDF   HTML
M. Corkum, R. Urquhart, G. Kephart, J.A. Hayden, G. Porter
Vol 24, No 5 (2017) Breast cancer and dermatomyositis: a case study and literature review Abstract   PDF   HTML
E. Hendren, O. Vinik, H. Faragalla, R. Haq
Vol 20, No 1 (2013) Breast cancer and the environment: what is left to learn? Details   PDF   HTML
S. Narod
Vol 20, No 5 (2013) Breast cancer and the environment: why research and preventive action are needed Abstract   PDF   HTML
J.T. Brophy, M.M. Keith, R. Park, A. Watterson, M. Gilbertson, R. DeMatteo
Vol 22, No 5 (2015) Breast cancer screening panels continue to confuse the facts and inject their own biases Abstract   PDF   HTML
D.B. Kopans
Vol 20, No 2 (2013) Breast cancer survivorship and South Asian Women: understanding about the follow-up care plan and perspectives and preferences for information post treatment Abstract   PDF   HTML
S. Singh-Carlson, F. Wong, L. Martin, S.K.A. Nguyen
Vol 24, No 3 (2017) Breast magnetic resonance imaging: are those who need it getting it? Abstract   PDF   HTML
S. Tan, J. David, L. Lalonde, M. El Khoury, M. Labelle, R. Younan, E. Patocskai, J. Richard, I. Trop
2008: Presentations from the Integrating Wellness into Cancer Care Conference Bringing wellness back into health care: the role of social networks Abstract   PPT Presentation
Alex R. Jadad
Vol 14, No 6 (2007) Broad funding for oxaliplatin in Ontario Details   PDF
Derek J Jonker
Vol 24, No 3 (2017) Budget impact analysis of a breast rapid diagnostic unit Abstract   PDF   HTML
M. Elmi, H. Hussain, S. Nofech-Mozes, B. Curpen, A. Leahey, N. Look Hong
Vol 23, No 6 (2016) Burden of illness for metastatic melanoma in Canada, 2011–2013 Abstract   PDF   HTML
D.S. Ernst, T. Petrella, A.M. Joshua, A. Hamou, M. Thabane, S. Vantyghem, F. Gwadry-Sridhar
Vol 23, No 2 (2016) But other than mesothelioma? An estimate of the proportion of work-related cancers in Quebec Abstract   PDF   HTML
F. Labrèche, P. Duguay, A. Boucher, R. Arcand
Vol 21, No 2 (2014) Can oncologists predict survival for patients with progressive disease after standard chemotherapies? Abstract   PDF   HTML
T.K. Taniyama, K. Hashimoto, N. Kastumata, A. Hirakawa, K. Yonemori, M. Yunokawa, C. Shimizu, K. Tamura, M. Ando, Y. Fujiwara
Vol 23, No 3 (2016) Can the referring surgeon enhance accrual of breast cancer patients to medical and radiation oncology trials? The ENHANCE study Abstract   PDF   HTML
A. Arnaout, I. Kuchuk, N. Bouganim, G. Pond, S. Verma, R. Segal, S. Dent, S. Gertler, X. Song, F. Kanji, M. Clemons
Vol 22, No 2 (2015) Canadian cancer screening disparities: a recent historical perspective Abstract   PDF   HTML
J. Kerner, J. Liu, K. Wang, S. Fung, C. Landry, G. Lockwood, L. Zitzelsberger, V. Mai
Vol 18, No 5 (2011) Canadian College of Medical Geneticists guidelines for the indications, analysis, and reporting of cancer specimens Abstract   PDF   HTML
A. J. Dawson, J. McGowan-Jordan, J. Chernos, J. Xu, J. Lavoie, J.-C. Wang, M. R. Steinraths, S. Shetty
Vol 22, No 2 (2015) Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 1: prophylaxis Abstract   PDF   HTML
J.C. Easaw, M.A. Shea-Budgell, C.M.J. Wu, P.M. Czaykowski, J. Kassis, B. Kuehl, H.J. Lim, M. MacNeil, D. Martinusen, P.A. McFarlane, E. Meek, O. Moodley, S. Shivakumar, V. Tagalakis, S. Welch, P. Kavan
101 - 200 of 1462 Items << < 1 2 3 4 5 6 7 8 9 10 > >>